Michael O Sullivan - 29 Jul 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Reporting relationship: Chief Financial Officer
Issuer ticker: OGEN
Reported as of: 29 Jul 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Aug 2022, 16:38:15 UTC
Prior SEC filing: 24 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Michael O. Sullivan

Key filing fact

Michael O Sullivan filed Form 4 for ORAGENICS INC (OGEN) on 02 Aug 2022.

Key facts

This page summarizes Michael O Sullivan's Form 4 filing for ORAGENICS INC (OGEN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Aug 2022, 16:38.

Change

Previous filing in this sequence was filed on 24 Jun 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OGEN transaction Derivative

Employee Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +200,000
Change %
Price: $0.000000
Shares after: 200,000
Date: 29 Jul 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 200,000
Exercise price: $0.3562
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an annual award of options to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan, that vest evenly in three tranches. One third of the options vest on the first anniversary of the grant date, the second third of the options vest on the second anniversary of the grant date and the final third vest on the third anniversary of the grant date. The option exercise price is the closing price on the date of the grant, July 29, 2022.